The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Almirall Hermal GmbH; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck Serono; Merck Sharp & Dohme; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - 4SC; Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Pierre Fabre; Roche/Genentech
Research Funding - Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pierre Fabre; Roche/Genentech
Overall survival in COLUMBUS: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) vs vemurafenib (VEM) or enco in BRAF-mutant melanoma.
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Incyte; MedImmune; Merck Serono; Merck Sharp & Dohme; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Syndax
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
 
Helen Gogas
Honoraria - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Ana M. Arance
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Mario Mandalà
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Research Funding - Roche
 
Gabriella Liszkay
Consulting or Advisory Role - Amgen; Amicus Therapeutics; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
 
Claus Garbe
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; LEO Pharma; MSD; Novartis; Philogen; Roche
Research Funding - Bristol-Myers Squibb; Roche
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - 4SC; Amgen; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Ivana Krajsova
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Ralf Gutzmer
No Relationships to Disclose
 
Vanna Chiarion-Sileni
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Caroline Dutriaux
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Roche
 
Jan Willem de Groot
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; MSD; Roche
 
Naoya Yamazaki
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb; MSD; Novartis; Ono Pharmaceutical
 
Carmen Loquai
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; LEO Pharma; MSD; Novartis; Pierre Fabre; Roche
 
Laure A. De Parseval
No Relationships to Disclose
 
Michael D Pickard
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Victor Sandor
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo; Strata Oncology; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Asana Biosciences; Bristol-Myers Squibb; Genentech; Incyte; Lilly; Loxo; Merck; Novartis; Oncoceutics; Roche; Sanofi; Shattuck Labs; Tolero Pharmaceuticals
Research Funding - Novartis; Sanofi